RBF Capital’s Merck MRK Stock Holding History

RBF Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,480	Closed	-$568K	–	305
2014 Q4	$568K	Buy	+10,480	New	+$584K	0.12%	149

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RBF Capital's MRK Position: Q1 2015 in Review

RBF Capital sold out of Merck (MRK) in Q1 2015, closing a stake of 10,480 shares — an estimated $568K sold.

RBF Capital first reported a position in MRK in Q4 2014 and held it in 1 quarter. The position peaked at $568K in Q4 2014. 1,711 funds tracked by Wall St. Rank hold MRK as of Q1 2015.

RBF Capital reported no remaining Merck position as of Q1 2015 after selling out during the quarter.
RBF Capital sold 10,480 Merck shares in Q1 2015, an estimated $568K.
RBF Capital first reported a position in Merck in Q4 2014 and held it in 1 quarter.
RBF Capital's Merck position peaked at $568K in Q4 2014.
1,711 funds tracked by Wall St. Rank held Merck as of Q1 2015.

Based on RBF Capital's 13F filing for Q1 2015, filed 14 May 2015.